A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
- 13 July 1978
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 299 (2) , 53-59
- https://doi.org/10.1056/nejm197807132990201
Abstract
Five hundred and eighty-five patients with threatened stroke were followed in a randomized clinical trial for an average of 26 months to determine whether aspirin or sulfinpyrazone, singly or in combination, influence the subsequent occurrence of continuing transient ischemic attacks, stroke or death.Keywords
This publication has 13 references indexed in Scilit:
- Platelets, Drugs and Longevity in a Geriatric PopulationPublished by S. Karger AG ,2015
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.Circulation, 1975
- Transient ischemic attacks in a communityPublished by American Medical Association (AMA) ,1969
- Joint study of extracranila arterial occlusion. 3. Progress report of controlled study of long-term survival in patients with and without operationJAMA, 1969
- Clinical and angiographic correlates of cerebrovascular insufficiencyThe American Journal of Medicine, 1968
- IMPAIRED PLATELET/CONNECTIVE-TISSUE REACTION IN MAN AFTER ASPIRIN INGESTIONThe Lancet, 1967
- LONG-TERM ANTICOAGULANT THERAPY IN TRANSIENT CEREBRAL ISCHÆMIC ATTACKSThe Lancet, 1965
- Observations of the fundus oculi in transient monocular blindnessNeurology, 1959